ReviewBiomedicines2023

Shifting from a Biological-Agnostic Approach to a Molecular-Driven Strategy in Rare Cancers: Ewing Sarcoma Archetype.

Aldo Caltavituro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.